Literature DB >> 16680451

Superoxide dismutase 1 modulates expression of transferrin receptor.

Ruth Danzeisen1, Tilmann Achsel, Ulrich Bederke, Mauro Cozzolino, Claudia Crosio, Alberto Ferri, Malte Frenzel, Edith Butler Gralla, Lea Huber, Albert Ludolph, Monica Nencini, Giuseppe Rotilio, Joan Selverstone Valentine, Maria Teresa Carrì.   

Abstract

Copper-zinc superoxide dismutase (SOD1) plays a protective role against the toxicity of superoxide, and studies in Saccharomyces cerevisiae and in Drosophila have suggested an additional role for SOD1 in iron metabolism. We have studied the effect of the modulation of SOD1 levels on iron metabolism in a cultured human glial cell line and in a mouse motoneuronal cell line. We observed that levels of the transferrin receptor and the iron regulatory protein 1 were modulated in response to altered intracellular levels of superoxide dismutase activity, carried either by wild-type SOD1 or by an SOD-active amyotrophic lateral sclerosis (ALS) mutant enzyme, G93A-SOD1, but not by a superoxide dismutase inactive ALS mutant, H46R-SOD1. Ferritin expression was also increased by wild-type SOD1 overexpression, but not by mutant SOD1s. We propose that changes in superoxide levels due to alteration of SOD1 activity affect iron metabolism in glial and neuronal cells from higher eukaryotes and that this may be relevant to diseases of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680451     DOI: 10.1007/s00775-006-0099-4

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  54 in total

1.  Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors.

Authors:  B Vaisman; E Fibach; A M Konijn
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Biomarkers of oxidative stress are significantly elevated in Down syndrome.

Authors:  S V Jovanovic; D Clements; K MacLeod
Journal:  Free Radic Biol Med       Date:  1998-12       Impact factor: 7.376

3.  Ferritin and the response to oxidative stress.

Authors:  K Orino; L Lehman; Y Tsuji; H Ayaki; S V Torti; F M Torti
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

Review 4.  Down's syndrome: a pathology involving the lack of balance of reactive oxygen species.

Authors:  J Kedziora; G Bartosz
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

Review 5.  Iron homeostasis, oxidative stress, and DNA damage.

Authors:  R Meneghini
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

6.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

7.  Oxidative stress and iron are implicated in fragmenting vacuoles of Saccharomyces cerevisiae lacking Cu,Zn-superoxide dismutase.

Authors:  L B Corson; J Folmer; J J Strain; V C Culotta; D W Cleveland
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  Down-regulation of iron regulatory protein 1 activities and expression in superoxide dismutase 1 knock-out mice is not associated with alterations in iron metabolism.

Authors:  Rafal R Starzynski; Pawel Lipinski; Jean-Claude Drapier; Alexandre Diet; Ewa Smuda; Teresa Bartlomiejczyk; Mikolaj A Gralak; Marcin Kruszewski
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

Review 9.  Aconitase, a two-faced protein: enzyme and iron regulatory factor.

Authors:  H Beinert; M C Kennedy
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

10.  Subunit-destabilizing mutations in Drosophila copper/zinc superoxide dismutase: neuropathology and a model of dimer dysequilibrium.

Authors:  J P Phillips; J A Tainer; E D Getzoff; G L Boulianne; K Kirby; A J Hilliker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more
  12 in total

1.  Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.

Authors:  E F Goodall; M S Haque; K E Morrison
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

2.  Catalytic activities of dismution reactions of Cu(bpy)Br(2) compound and its derivatives as SOD mimics: a theoretical study.

Authors:  Qingxia Lu; Xichen Li; Yan Wang; Guangju Chen
Journal:  J Mol Model       Date:  2009-05-07       Impact factor: 1.810

Review 3.  Flightless flies: Drosophila models of neuromuscular disease.

Authors:  Thomas E Lloyd; J Paul Taylor
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice.

Authors:  Suh Young Jeong; Daniel R Crooks; Hayden Wilson-Ollivierre; Manik C Ghosh; Rachid Sougrat; Jaekwon Lee; Sharon Cooperman; James B Mitchell; Carole Beaumont; Tracey A Rouault
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

5.  Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Authors:  Satoru Oshiro; Masaki S Morioka; Masataka Kikuchi
Journal:  Adv Pharmacol Sci       Date:  2011-10-12

Review 6.  Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.

Authors:  Anmu Xie; Jing Gao; Lin Xu; Dongmei Meng
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

7.  Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis.

Authors:  Muddasir Qureshi; Robert H Brown; Jack T Rogers; Merit E Cudkowicz
Journal:  Open Neurol J       Date:  2008-09-12

8.  Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application.

Authors:  Chen Benkler; Daniel Offen; Eldad Melamed; Lana Kupershmidt; Tamar Amit; Silvia Mandel; Moussa B H Youdim; Orly Weinreb
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

9.  Mice Overexpressing Both Non-Mutated Human SOD1 and Mutated SOD1(G93A) Genes: A Competent Experimental Model for Studying Iron Metabolism in Amyotrophic Lateral Sclerosis.

Authors:  Anna Gajowiak; Agnieszka Styś; Rafał R Starzyński; Aleksandra Bednarz; Małgorzata Lenartowicz; Robert Staroń; Paweł Lipiński
Journal:  Front Mol Neurosci       Date:  2016-01-06       Impact factor: 5.639

10.  hmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway.

Authors:  Malgorzata Halon-Golabek; Andzelika Borkowska; Jan J Kaczor; Wieslaw Ziolkowski; Damian J Flis; Narcyz Knap; Kajetan Kasperuk; Jedrzej Antosiewicz
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-01-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.